Literature DB >> 24298226

Linear No-Threshold Model VS. Radiation Hormesis.

Mohan Doss1.   

Abstract

The atomic bomb survivor cancer mortality data have been used in the past to justify the use of the linear no-threshold (LNT) model for estimating the carcinogenic effects of low dose radiation. An analysis of the recently updated atomic bomb survivor cancer mortality dose-response data shows that the data no longer support the LNT model but are consistent with a radiation hormesis model when a correction is applied for a likely bias in the baseline cancer mortality rate. If the validity of the phenomenon of radiation hormesis is confirmed in prospective human pilot studies, and is applied to the wider population, it could result in a considerable reduction in cancers. The idea of using radiation hormesis to prevent cancers was proposed more than three decades ago, but was never investigated in humans to determine its validity because of the dominance of the LNT model and the consequent carcinogenic concerns regarding low dose radiation. Since cancer continues to be a major health problem and the age-adjusted cancer mortality rates have declined by only ∼10% in the past 45 years, it may be prudent to investigate radiation hormesis as an alternative approach to reduce cancers. Prompt action is urged.

Entities:  

Keywords:  Adaptive Response; Atomic Bomb Survivors; LNT Model; Radiation Hormesis

Year:  2013        PMID: 24298226      PMCID: PMC3834742          DOI: 10.2203/dose-response.13-005.Doss

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  58 in total

1.  Fifty years of progress in chronic disease epidemiology and control.

Authors:  Patrick L Remington; Ross C Brownson
Journal:  MMWR Suppl       Date:  2011-10-07

Review 2.  Biological effects of low level exposures to ionizing radiation: theory and practice.

Authors:  Shu-Zheng Liu
Journal:  Hum Exp Toxicol       Date:  2010-04       Impact factor: 2.903

3.  Further study of prolongation of life span associated with immunological modification by chronic low-dose-rate irradiation in MRL-lpr/lpr mice: effects of whole-life irradiation.

Authors:  Yasuhiro Ina; Kazuo Sakai
Journal:  Radiat Res       Date:  2005-04       Impact factor: 2.841

4.  Radiation hormesis and radioadaptive response in Drosophila melanogaster flies with different genetic backgrounds: the role of cellular stress-resistance mechanisms.

Authors:  A A Moskalev; E N Plyusnina; M V Shaposhnikov
Journal:  Biogerontology       Date:  2011-01-14       Impact factor: 4.277

5.  The linear no-threshold debate: where do we go from here?

Authors:  K L Mossman
Journal:  Med Phys       Date:  1998-03       Impact factor: 4.071

6.  The LNT model is appropriate for the estimation of risk from low-level (less than 100 mSv/year) radiation, and low levels of radon in homes should be considered harmful to health.

Authors:  D J Strom; J R Cameron; B L Cohen
Journal:  Med Phys       Date:  1998-03       Impact factor: 4.071

7.  The importance of adaptive response in cancer prevention and therapy.

Authors:  Mohan Doss
Journal:  Med Phys       Date:  2013-03       Impact factor: 4.071

8.  Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment.

Authors:  Alexander M Vaiserman
Journal:  Dose Response       Date:  2010-01-18       Impact factor: 2.658

9.  Adaptive immunity maintains occult cancer in an equilibrium state.

Authors:  Catherine M Koebel; William Vermi; Jeremy B Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Journal:  Nature       Date:  2007-11-18       Impact factor: 49.962

10.  Radiobiological basis of low-dose irradiation in prevention and therapy of cancer.

Authors:  Myron Pollycove
Journal:  Dose Response       Date:  2006-11-27       Impact factor: 2.658

View more
  23 in total

1.  Point/Counterpoint: low-dose radiation is beneficial, not harmful.

Authors:  Mohan Doss; Mark P Little; Colin G Orton
Journal:  Med Phys       Date:  2014-07       Impact factor: 4.071

2.  Radiation doses from radiological imaging do not increase the risk of cancer.

Authors:  M Doss
Journal:  Br J Radiol       Date:  2014-02-20       Impact factor: 3.039

3.  Low dose radiation adaptive protection to control neurodegenerative diseases.

Authors:  Mohan Doss
Journal:  Dose Response       Date:  2013-09-12       Impact factor: 2.658

4.  Epidemiology Without Biology: False Paradigms, Unfounded Assumptions, and Specious Statistics in Radiation Science (with Commentaries by Inge Schmitz-Feuerhake and Christopher Busby and a Reply by the Authors).

Authors:  Bill Sacks; Gregory Meyerson; Jeffry A Siegel
Journal:  Biol Theory       Date:  2016-06-17

5.  Comments on "Space: The Final Frontier-Research Relevant to Mars".

Authors:  S M J Mortazavi; J J Bevelacqua; K W Fornalski; James Welsh; Mohan Doss
Journal:  Health Phys       Date:  2018-03       Impact factor: 1.316

6.  LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy.

Authors:  Gaeul Park; Beomseok Son; JiHoon Kang; Sungmin Lee; Jaewan Jeon; Joo-Hyung Kim; Gi-Ra Yi; HyeSook Youn; Changjong Moon; Seon Young Nam; BuHyun Youn
Journal:  Mol Ther       Date:  2018-10-26       Impact factor: 11.454

7.  Effect of comfort pads and incubator design on neonatal radiography.

Authors:  Xia Jiang; Michael Baad; Ingrid Reiser; Kate A Feinstein; Zhengfeng Lu
Journal:  Pediatr Radiol       Date:  2015-09-03

8.  Remedy for radiation fear - discard the politicized science.

Authors:  Jerry M Cuttler
Journal:  Dose Response       Date:  2014-03-13       Impact factor: 2.658

9.  Correcting systemic deficiencies in our scientific infrastructure.

Authors:  Mohan Doss
Journal:  Dose Response       Date:  2013-12-06       Impact factor: 2.658

10.  The Inhibitory Effects of Low-Dose Ionizing Radiation in IgE-Mediated Allergic Responses.

Authors:  Hae Mi Joo; Su Jin Kang; Seon Young Nam; Kwang Hee Yang; Cha Soon Kim; In Kyung Lee; Ji Young Kim
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.